To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Peri-Articular Corticosteroid Injection Improves Pain 1-Day vs Intravenous Injection in TKA

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
March 2021

Peri-Articular Corticosteroid Injection Improves Pain 1-Day vs Intravenous Injection in TKA

Vol: 11| Issue: 1| Number:5| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Comparison of Intravenous and Periarticular Administration of Corticosteroids in Total Knee Arthroplasty: A Prospective, Randomized Controlled Study

J Bone Joint Surg Am. 2021 Feb 17;103(4): 319-325

Contributing Authors:
K Hatayama M Terauchi A Oshima H Kakiage K Ikeda H Higuchi

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

One hundred patients with knee osteoarthritis (OA) scheduled for a unilateral total knee arthroplasty (TKA) were randomized to receive an intra-articular injection of dexamethasone (n=50) or peri-articular injection of triamcinolone acetonide (n=50). Outcomes of interest included the following: pain which was evaluated using the Numeric Rating Scale (NRS) at rest and during walking, nausea measure...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue